<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00565799</url>
  </required_header>
  <id_info>
    <org_study_id>07-178</org_study_id>
    <nct_id>NCT00565799</nct_id>
  </id_info>
  <brief_title>A Pilot Study of Metabolic Effects of Omentectomy</brief_title>
  <acronym>OMT</acronym>
  <official_title>A Pilot Study of Metabolic Effects of Omentectomy in Obese Patients With Type 2 Diabetes Mellitus Treated With Laparoscopic Adjustable Gastric Banding (LAGB)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      PROTOCOL SUMMARY&#xD;
&#xD;
      Type of Study: Pilot, randomized and single center trial Test Procedure: Omentectomy Aim 1.&#xD;
      Determine the effect of omentectomy on 1) insulin sensitivity, 2) beta cell function and 3)&#xD;
      plasma markers of inflammation We hypothesize that removal of omental fat increases insulin&#xD;
      sensitivity and pancreatic sensitivity to glucose, and decreases systemic inflammation.&#xD;
&#xD;
      Aim 2. Identify genes and proteins in adipocytes from obese patients that affect clinical&#xD;
      presentation versus those that are affected by obesity for future study.&#xD;
&#xD;
      We hypothesize that the genetic samples will help us to identify genes and proteins in&#xD;
      adipocytes from obese patients that affect clinical presentation versus those that are&#xD;
      affected by obesity and help us to design future obesity genetic studies.&#xD;
&#xD;
      Total Enrollment Number: 30 patients who are scheduled to undergo bariatric surgery for&#xD;
      weight loss at New York University Medical Center will be invited to participate in this&#xD;
      study. Subjects will be randomly assigned, by using a computer-generated randomization&#xD;
      scheme, in a single-blind fashion to either the omentectomy (n=15) or control group (n=15).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion Criteria:&#xD;
&#xD;
        -  Patients who consented to undergo LAGB for weight loss and consent to participate in&#xD;
           this study&#xD;
&#xD;
        -  BMI ≥35 kg/m2&#xD;
&#xD;
        -  Confirmed T2DM treated with oral agents and/or only diet therapy&#xD;
&#xD;
        -  Age 18-64 years&#xD;
&#xD;
      Exclusion Criteria:&#xD;
&#xD;
        -  Insulin therapy&#xD;
&#xD;
        -  Weight change (&gt;2% body weight) within 4 weeks before surgery&#xD;
&#xD;
        -  Patients with T2DM for more than 10 years&#xD;
&#xD;
      Research Design- Pilot Study Event Week (approximate) Medical Screening (in conjunction with&#xD;
      routine pre-op visit) -4 OGTT &amp; randomization -2 Preliminary genetic testing for the future&#xD;
      study (blood sample) -2 Surgery with or without omentectomy 0 Preliminary genetic testing for&#xD;
      the future study (fat sample) 0 Weight stabilization visit (in conjunction with routine&#xD;
      post-op visit) 2 Weight stabilization visit (in conjunction with routine post-op visit) 4&#xD;
      OGTT 6&#xD;
&#xD;
      STUDY PLAN&#xD;
&#xD;
      Study has approved by IRB, NYU School of Medicine Committee, GCRC, and Bellevue Hospital.&#xD;
&#xD;
      Study initiation date: November 01, 2007&#xD;
&#xD;
      Enrollment period: Nov. 2007 to Nov. 2008&#xD;
&#xD;
      Study period: Nov. 2007 to Jan 2008&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Conflicting interim data&#xD;
  </why_stopped>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>1) insulin sensitivity, 2) beta cell function and 3) plasma markers of inflammation</measure>
    <time_frame>6 week post op</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Identify genes and proteins in adipocytes from obese patients that affect clinical presentation versus those that are affected by obesity for future study.</measure>
    <time_frame>6 week post op</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Patients Who Consented to Undergo Laparoscopic Gastric Banding Surgery for Weight Loss and Consent to Participate in This studyBMI ≥35 kg/m2</condition>
  <condition>Confirmed Type 2 Diabetes Treated With Oral Agents and/or Only Diet Therapy</condition>
  <condition>Age 18-64 Years</condition>
  <arm_group>
    <arm_group_label>1. Omentectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>LAGB &amp; Omentectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 No Omentectomy</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>LAGB Only</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Omentectomy</intervention_name>
    <description>Removing the omentum</description>
    <arm_group_label>1. Omentectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>Only LAGB without Omentectomy</description>
    <arm_group_label>2 No Omentectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who consented to undergo LAGB for weight loss and consent to participate in&#xD;
             this study&#xD;
&#xD;
          -  BMI ≥35 kg/m2&#xD;
&#xD;
          -  Confirmed T2DM treated with oral agents and/or only diet therapy&#xD;
&#xD;
          -  Age 18-64 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Insulin therapy&#xD;
&#xD;
          -  Weight change (&gt;2% body weight) within 4 weeks before surgery&#xD;
&#xD;
          -  Patients with T2DM for more than 10 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christine Ren, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NYU School of Medicine</name>
      <address>
        <city>NY</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://nyuweightloss.org</url>
    <description>Related Info</description>
  </link>
  <verification_date>November 2015</verification_date>
  <study_first_submitted>November 28, 2007</study_first_submitted>
  <study_first_submitted_qc>November 28, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2007</study_first_posted>
  <last_update_submitted>November 18, 2015</last_update_submitted>
  <last_update_submitted_qc>November 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 20, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>DM</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

